1. Home
  2. SAIC vs TMDX Comparison

SAIC vs TMDX Comparison

Compare SAIC & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

SAIC

SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

HOLD

Current Price

$114.73

Market Cap

4.8B

Sector

Technology

ML Signal

HOLD

Logo TransMedics Group Inc.

TMDX

TransMedics Group Inc.

HOLD

Current Price

$135.02

Market Cap

4.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SAIC
TMDX
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.8B
4.2B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
SAIC
TMDX
Price
$114.73
$135.02
Analyst Decision
Buy
Buy
Analyst Count
9
8
Target Price
$119.44
$144.25
AVG Volume (30 Days)
555.9K
623.6K
Earning Date
12-04-2025
02-26-2026
Dividend Yield
1.30%
N/A
EPS Growth
33.14
170.70
EPS
7.83
2.54
Revenue
$7,350,000,000.00
$566,354,000.00
Revenue This Year
N/A
$38.81
Revenue Next Year
$1.75
$20.49
P/E Ratio
$14.56
$54.05
Revenue Growth
N/A
41.20
52 Week Low
$84.16
$55.00
52 Week High
$124.11
$156.00

Technical Indicators

Market Signals
Indicator
SAIC
TMDX
Relative Strength Index (RSI) 75.22 58.51
Support Level $100.00 $134.00
Resistance Level $103.58 $133.29
Average True Range (ATR) 2.85 5.02
MACD 0.97 1.46
Stochastic Oscillator 95.03 69.70

Price Performance

Historical Comparison
SAIC
TMDX

About SAIC SCIENCE APPLICATIONS INTERNATIONAL CORPORATION

Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management and operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the Department of Defence (DoD) and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: